BIOCHEMICAL SOCIETY TRANSACTIONS appeared to increase, and that of the serine of the previous cycle decreased. In the sequence shown in Fig. 1 , the gap would correspond to a serine: the stretch Lys-Arg-Asn-SerSer would clearly be a canonical substrate site for the cyclic AMP-dependent protein kinase. Derivation of the labelled peptide with ethanethiol to convert phosphoserine into ethylcysteine, which, at variance with phosphoserine, can be identified in the normal amino acid sequencing procedures, showed that the missing cycle indeed corresponded to ethylcysteine. The data on the cyclic AMP phosphorylation can be used to extend the model for the regulation of the ATPase by calmodulin suggested above. The C-terminal domain containing the substrate sequence for the cyclic AMP-directed phosphorylation has a strong acid character, and could thus interact in the pump in sifu with the basic calmodulin-binding domain. The latter domain, on the other hand, probably interacts also with the acidic sequence (the putative Ca2+-binding site, see above) N-terminal to it. The conformational change induced by the cyclic AMP-directed phosphorylation could alter the conformation of the complex formed by the calmodulin-binding domain and the putative Ca2 + -binding sequence, permitting free Ca2+ access to the latter.
A major class of membrane transport proteins are the cotransporters (symporters). They are responsible for the cellular uptake of small molecules against their concentration gradients. In prokaryotes, such as the enteric bacteria, they are generally driven by proton electrochemical potential gradients, but in eukaryotes, they are driven by Na+ electrochemical potential gradients. The best known example of Na +-cotransport (symport) is the intestinal brush border Na+/glucose carrier. This is primarily responsible for the active absorption of glucose across the intestinal epithelium from gut to blood.
We have cloned the rabbit intestinal brush border Na+/ glucose cotransporter by a novel procedure called expression cloning [l] . Briefly, this depended on (i) our ability to express Na+ /glucose uptake into Xenopus oocytes after microinjection of intestinal mRNA [2] , and (ii) enrichment of the mRNA coding for the transporter by preparative electrophoresis. cDNA was made from the enriched mRNA fraction, and this was used to make a cDNA library in a transcription vector. The clones were screened by synthesizing mRNA in vitro, injecting it into oocytes, and screening for Na+-dependent glucose uptake. A single clone was isolated that accounted for all the known properties of intestinal glucose transport, i.e., uptake was specific, saturable, Na+ dependent, and inhibited by phlorizin 11 I. The properties of the cloned transporter are essentially identical to those of the transporter in the native rabbit brush border [3] .
The clone codes for a 662 amino acid polypeptide with a molecular mass of 73080, close to the M , of the intact brush border transport protein [4] . Secondary structure analysis predicts a model ( Fig. 1 ) with 11 membrane-spanning domains, with a large hydrophilic loop between membrane segments 7 and 8, and another between segments 10 and 1 1. We have recently used the rabbit clone as a probe to isolate a functional clone from human intestinal A gt 10 library. This codes for a 664 amino acid polypeptide which shows 94% homology with the rabbit sequence [5] . There is no recognizable sequence similarity between these Na+ /glucose cotransporters and any other sugar transporter, including mammalian facilitated glucose carriers.
There are two potential N-linked glycosylation sites (consensus sequences Asn-Xaa-Thr/Ser) at positions 248 and 306 in both the rabbit and human sequences (Fig. 1) . We have studied glycosylation using in vitro translation of RNA transcripts coding for the rabbit Na+ /glucose cotransporter.
In the absence of pancreatic microsomes, the M , of the protein on SDS/polyacrylamide-gel electrophoresis was 52000. The discrepancy between the M , and the predicted molecular mass of 73083 Da is a common observation for membrane proteins, and is explained, in part, by the ability of hydrophobic membrane proteins to bind more SDS than other proteins. In vifro translation of the full-length transcript in the presence of canine pancreatic microsomes increased M , by 6000 to 58000, and this increase was reversed by endoglycosidase H. We conclude that one or both of the sites is glycosylated [6] . Similar increases in size due to N-linked glycosylation were observed in similar experiments with partial transcripts coding for polypeptides 1-289 and 1-394, but not with a partial transcript coding for polypeptide 1-232 (Fig. 1) . This suggests that only Asn-248 is glycosylated. Since glycosylation is generally restricted to the extracellular domain of membrane proteins, this would place the N-terminus of the polypeptide on the cytoplasmic face of the membrane in our model (Fig. 1) . The functional Ab-N-7 Fig. 1 . Proposed secondary structure of the rabbit intestinal brush border Na'lglucose cotransporter (ajier Hediger et al.
[I]) The human intestinal brush border protein has a similar structure [5] . Only Asn-248 is glycosylated, and so the N-terminus of the protein is predicted to lie on the cytoplasmic face of the plasma membrane. Partial transcripts of the cDNA were used to translate truncated versions of the protein to examine which of the two potential glycosylation sites are used. The 'scissors' point to positions where the sequence was truncated on each side of Asn-248 and -306 using unique restriction sites in the cDNA sequence. Ab-N, Ab-E, and Ab-C were generated from peptide sequences at three different sites in the structure. Ab-N failed to immunoreact with either intestinal or renal brush border membranes.
role of the glycosylation of Asn-248 was examined by testing the effect o f tunicamycin, an inhibitor of N-linked glycosylation, on the expression of the cotransporter in oocytes. Tunicamycin at a concentration ( 2 pg/ml) that did not affect translation of injected mRNA [7] inhibited expression of Na'-dependent sugar uptake by 80%. The role of N-linked glycosylation in the functional expression of the rabbit Na' / glucose cotransporter in oocytes may be linked to insertion of the protein into the plasma membrane, protein assembly, transport function, or protein turnover. Additional experiments are in progress to evaluate these alternative explanations.
Polyclonal antibodies were raised to three defined regions of the predicted secondary structure (Fig. I ). Peptides were synthesized corresponding to predicted sequences at the Nterminal region (Ab-N), a region in the large hydrophilic loop between membrane segments 7 and 8 (Ab-E), and in the large hydrophilic loop between membrane segments 10 and 11 (Ab-C). These peptides were used to raise polyclonal antibodies in rabbits. With both human and rabbit brush border membranes, antibodies Ab-E and Ab-C specifically recognized a band on Western blots with an M , of 70000-75 000 which is close to previous estimates of the size of the intestinal Na'/glucose cotransporter 14, 8, 91 . Preliminary experiments also indicate that Ab-E immunoreacts with a 76000 M , band in LLC-PK1 (a pig renal cell line) brush borders. Again, this agrees with estimates of the size of the transporter in pig renal cortex [lo] . These results indicate a close structural similarity between the intestinal and renal cotransporters. This has been confirmed by Northern blot analysis of renal mRNA using the intestinal probes.
Finally, we have determined the chromosomal location of the human Na ' /glucose cotransporter gene [ 1 11. Southern blots of genomic DNA from mouse-human somatic cell hybrids showed that the gene resides on chromosome 22. Further analysis of hamster-human hybrids selectively retaining portions of this chromosome permitted the assignment of the gene to the q l l . 2 -qter region. Currently, we are mapping the gene in finer detail. This will allow us in the future to search for the gene defect in glucose-galactose malabsorption syndrome.
